- Home
- ESEA vs TIL Comparison
ESEA vs TIL Comparison
Compare ESEA & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- TIL
- Stock Information
- Founded
- ESEA 2005
- TIL 2018
- Country
- ESEA Greece
- TIL United States
- Employees
- ESEA N/A
- TIL N/A
- Industry
- ESEA Marine Transportation
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- TIL Health Care
- Exchange
- ESEA Nasdaq
- TIL Nasdaq
- Market Cap
- ESEA 208.2M
- TIL 230.1M
- IPO Year
- ESEA 2006
- TIL 2021
- Fundamental
- Price
- ESEA $48.62
- TIL $24.49
- Analyst Decision
- ESEA Strong Buy
- TIL Buy
- Analyst Count
- ESEA 1
- TIL 5
- Target Price
- ESEA $62.00
- TIL $119.00
- AVG Volume (30 Days)
- ESEA 50.8K
- TIL 310.3K
- Earning Date
- ESEA 08-05-2025
- TIL 08-12-2025
- Dividend Yield
- ESEA 5.33%
- TIL N/A
- EPS Growth
- ESEA 21.86
- TIL N/A
- EPS
- ESEA 18.62
- TIL N/A
- Revenue
- ESEA $222,525,034.00
- TIL N/A
- Revenue This Year
- ESEA $5.14
- TIL N/A
- Revenue Next Year
- ESEA $3.76
- TIL N/A
- P/E Ratio
- ESEA $2.54
- TIL N/A
- Revenue Growth
- ESEA 14.62
- TIL N/A
- 52 Week Low
- ESEA $24.58
- TIL $9.70
- 52 Week High
- ESEA $50.82
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- ESEA 61.35
- TIL 47.69
- Support Level
- ESEA $46.59
- TIL $21.80
- Resistance Level
- ESEA $50.50
- TIL $26.91
- Average True Range (ATR)
- ESEA 1.84
- TIL 3.52
- MACD
- ESEA -0.13
- TIL -0.37
- Stochastic Oscillator
- ESEA 53.62
- TIL 35.14
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.